Skip to main content
. 2016 Nov 23;16:238. doi: 10.1186/s12883-016-0748-3

Table 3.

Treatments and efficacy of treatments

Medications Patients (n = 54 patients)
Propranolol (n = 31 patients)
 Positive effect of propranolol 24 (77%)
 Mean posology, en milligram/day, range 109 (40–300)
 Mean length of treatment, months, range 57 (1–360)
Primidone (n = 16 patients)
 Positive effect of primidone 13 (81%)
 Mean posology, en milligram/day, range 338 (10–750)
 Mean length of treatment, months, range 15 (1–60)
Topiramate (n = 7 patients)
 Positive effect of topiramate 3 (43%)
 Mean posology, en milligram/day, range 75 (25–150)
 Mean length of treatment, months, range 11 (1–36)
Chronic high frequency thalamic stimulation 2 (4%)
HHS Vulnerability Disclosure